# GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases

> **NCT02115139** · PHASE2 · COMPLETED · sponsor: **Grupo Español Multidisciplinar de Melanoma** · enrollment: 58 (actual)

## Conditions studied

- Melanoma
- Brain Metastases

## Interventions

- **DRUG:** Ipilimumab

## Key facts

- **NCT ID:** NCT02115139
- **Lead sponsor:** Grupo Español Multidisciplinar de Melanoma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-04
- **Primary completion:** 2016-12-31
- **Final completion:** 2018-07-31
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2022-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02115139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02115139, "GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02115139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*